MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) — Charleston, South Carolina

MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Gastroesophageal Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122)?

MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) conducted?

MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) has 1 clinical trials on record, with 1 currently active. Their work covers Gastroesophageal Cancer.

Is MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) accredited by Crixeo Health?

MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.